Konrad, A; Vucurevic, G; Stoeter, P et al.
Correlation of brain white matter diffusion anisotropy and mean diffusivity with reaction time in an oddball taskNeuropsychobiology. Bd. 60. H. 2. 2009 S. 55-66
Fellgiebel, A; Kojro, E; Muller, MJ et al.
CSF APPs alpha and phosphorylated tau protein levels in mild cognitive impairment and dementia of Alzheimer's type.J Geriatr Psychiatry Neurol. Bd. 22. H. 1. 2009 S. 3-9
Waldschmitt, C; Hiemke, C; Eckermann, G
Das pharmakokinetische Interaktionspotenzial von DuloxetinPsychopharmakotherapie. Bd. 16. H. 1. 2009 S. 14-18
Schmitt, U; Tanimoto, N; Seeliger, M et al.
Detection of behavioral alterations and learning deficits in mice lacking synaptophysinNeuroscience. Bd. 162. H. 2. 2009 S. 234-43
Helander, A; Böttcher, M; Fehr, C et al.
Detection times for urinary ethyl glucuronide and ethyl sulfate in heavy drinkers during alkohol detoxificationAlcohol Alcohol. Bd. 44. H. 1. 2009 S. 55-61
Eidens, M; Weise, A; Prause, S et al.
Development and validation of a high-throughput screening method for two polymorphisms in the serotonin transporter gene.Mol Diagn Ther. Bd. 13. H. 1. 2009 S. 25-9
Fellgiebel, A; Keller, I; Marin, D et al.
Diagnostic utility of different MRI and MR angiography measures in Fabry disease.Neurology. Bd. 72. H. 1. 2009 S. 63-8
Drueke, B; Baetz, J; Boecker, M et al.
Differential effects of escitalopram on attention: a placebo-controlled, double-blind cross-over studyPsychopharmacology (Berl). Bd. 207. H. 2. 2009 S. 213-23
Schanz, B; Stranz, S
DRG in der Psychiatrie und PsychosomatikDie Schwester Der Pfleger. Bd. 48. H. 12. 2009 S. 1229-1231
Waldschmitt, C; Vogel, F; Pfuhlmann, B et al.
Duloxetine serum concentrations and clinical effects. Data from a therapeutic drug monitoring (TDM) surveyPharmacopsychiatry. Bd. 42. H. 5. 2009 S. 189-193